Fresenius Medical Care/$FMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Fresenius Medical Care
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Ticker
$FMS
Sector
Primary listing
NYSE
Employees
109,698
Headquarters
Website
FMS Metrics
BasicAdvanced
$12B
5.79
$3.87
0.94
$0.57
2.54%
Price and volume
Market cap
$12B
Beta
0.94
52-week high
$30.46
52-week low
$20.95
Average daily volume
576K
Dividend rate
$0.57
Financial strength
Current ratio
1.265
Quick ratio
0.852
Long term debt to equity
60.197
Total debt to equity
75.675
Dividend payout ratio (TTM)
43.19%
Interest coverage (TTM)
4.28%
Profitability
EBITDA (TTM)
2,763.017
Gross margin (TTM)
25.62%
Net profit margin (TTM)
4.98%
Operating margin (TTM)
8.39%
Effective tax rate (TTM)
21.23%
Revenue per employee (TTM)
$207,350
Management effectiveness
Return on assets (TTM)
3.19%
Return on equity (TTM)
7.93%
Valuation
Price to earnings (TTM)
5.79
Price to revenue (TTM)
0.289
Price to book
0.76
Price to tangible book (TTM)
-19.89
Price to free cash flow (TTM)
3.217
Free cash flow yield (TTM)
31.09%
Free cash flow per share (TTM)
6.966
Dividend yield (TTM)
2.54%
Forward dividend yield
2.54%
Growth
Revenue change (TTM)
1.51%
Earnings per share change (TTM)
83.60%
3-year revenue growth (CAGR)
0.39%
10-year revenue growth (CAGR)
2.42%
3-year earnings per share growth (CAGR)
13.53%
10-year earnings per share growth (CAGR)
0.71%
3-year dividend per share growth (CAGR)
9.98%
10-year dividend per share growth (CAGR)
6.42%
What the Analysts think about FMS
Majority rating from 5 analysts.
FMS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fresenius Medical Care stock?
Fresenius Medical Care (FMS) has a market cap of $12B as of April 04, 2026.
What is the P/E ratio for Fresenius Medical Care stock?
The price to earnings (P/E) ratio for Fresenius Medical Care (FMS) stock is 5.79 as of April 04, 2026.
Does Fresenius Medical Care stock pay dividends?
Yes, the Fresenius Medical Care (FMS) stock pays dividends to shareholders. As of April 04, 2026, the dividend rate is $0.57002 and the yield is 2.54%. Fresenius Medical Care has a payout ratio of 43.19% on a trailing twelve-month basis.
When is the next Fresenius Medical Care dividend payment date?
The next Fresenius Medical Care (FMS) dividend payment date is unconfirmed.
What is the beta indicator for Fresenius Medical Care?
Fresenius Medical Care (FMS) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.